LabCorp Added to S&P 500 Index

BURLINGTON, N.C., Nov. 3 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Standard & Poor's (S&P) added the company to the S&P 500 Index as of the close of trading on October 29, 2004.

Laboratory Corporation of America(R) Announces 2004 Third Quarter Results

EPS Increases 13.8 Percent to $0.66; Company Announces New Share Repurchase Program BURLINGTON, N.C., Oct 21, 2004 (PRNewswire-FirstCall via COMTEX) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) , the clinical laboratory industry's scientific leader, today announced financial

LabCorp(R) Scheduled to Present at the UBS Global Life Sciences Conference

BURLINGTON, N.C., Sept. 24 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Bradford T. Smith, executive vice president of corporate affairs, is scheduled to speak at the UBS Global Life Sciences Conference in New York, NY on

LabCorp(R) Scheduled to Present at the Banc of America Securities Annual Investment Conference

BURLINGTON, N.C., Sept. 17 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Bradford T. Smith, executive vice president of corporate affairs, is scheduled to speak at the Banc of America Securities Investment Conference in San

LabCorp(R) Announces Results of its Offer to Purchase Zero-Coupon Subordinated Notes Due 2021

BURLINGTON, N.C., Sept. 13 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that no holders of its zero coupon-subordinated notes elected to exercise their option to redeem their notes on September 11, 2004.

LabCorp(R) Scheduled to Present at the Thomas Weisel Partners Health Care Conference

BURLINGTON, N.C., Sept. 8 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Bradford T. Smith, executive vice president of corporate affairs, is scheduled to speak at the Thomas Weisel Partners Health Care Conference in Boston, MA

Arthur H. Rubenstein Named to LabCorp(R) Board of Directors

BURLINGTON, N.C., Aug. 2 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Arthur H. Rubenstein, MBBCh, has been elected to its Board of Directors, effective August 1, 2004. Dr. Rubenstein, 66, is the Dean of the University of

Laboratory Corporation of America(R) Announces 2004 Second Quarter Results

EPS Increases 16.7 Percent to $0.70; EBITDA Margin Hits 26.9 Percent of Net Sales; Operating Cash Flow Increases 19 Percent; Company Increases Annual EPS Guidance for 2004 BURLINGTON, N.C., July 22 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today

LabCorp(R) Announces New Non-Invasive Swab Test for Alpha1-Antitrypsin Deficiency

One in 12 People Have AAT Deficiency Gene; Early Detection Can Lead to Prevention or Reduction of Chronic Disease BURLINGTON, N.C., May 20 /PRNewswire-FirstCall/ -- Laboratory Corporation of America Holdings (LabCorp(R)) (NYSE: LH) today announced the offering of the only buccal swab test for

LabCorp(R) Scheduled to Present at the Banc of America Securities Health Care Conference

BURLINGTON, N.C., May 19 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Thomas P. Mac Mahon, Chairman and Chief Executive Officer, is scheduled to speak at the Banc of America Securities Health Care Conference in Las Vegas, NV on